ClinicalTrials.Veeva

Menu

Outcome Study of Double Bare Stent for Malignant Gastric Outlet Obstruction

N

National Cancer Center (NCC)

Status and phase

Unknown
Phase 4

Conditions

Gastric Outlet Obstruction Due to Malignancy

Treatments

Device: DoubleBare stent
Procedure: placement of double bare stent

Study type

Interventional

Funder types

Other

Identifiers

NCT02156505
NCCCTSMD12009

Details and patient eligibility

About

Self-expandable metallic stents provide effective palliation of malignant gastric outlet obstruction. However, uncovered stent are often associated with re-stenosis caused by tumor in-growth through the stent mesh. The Self-expandable metallic stents which has the design of smaller wire mesh size (double bare stent) were developed and used in Korea. This new design was developed to minimize the re-stenosis of uncovered stent, but the outcome is unknown. The end point of this study is the 8-weeks patency rate after placement of double bare as well as technical and clinical success rates.

Enrollment

49 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Malignant gastric outlet obstruction
  • Symptoms compatible with gastric outlet obstruction
  • An inoperable condition because of extent of disease or patient's conditions

Exclusion criteria

  • History of enteral stent placement, undergone gastric surgery.
  • Additional small bowel stenosis distal to gastric outlet obstruction.
  • Refuse to be enrolled to study.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

49 participants in 1 patient group

DoubleBare stent
Experimental group
Description:
Placement of double bare stent
Treatment:
Procedure: placement of double bare stent
Device: DoubleBare stent

Trial contacts and locations

1

Loading...

Central trial contact

Chan G Kim, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems